Eric J. Loumeau, Chief Legal Officer of AnaptysBio Inc. (ANAB), has demonstrated a consistent pattern of selling activity in the company’s stock over recent months, with no recorded purchases. Since September 2025, Loumeau has executed 13 sales totaling approximately $2.98 million, with transactions ranging from smaller dispositions like $6,625.59 on December 18, 2025, to larger blocks such as $540,000 on February 11, 2026. The sales have been accompanied by periodic acquisitions of shares through derivative transactions (coded "M"), though these appear to be part of equity compensation rather than open-market purchases.
Loumeau’s most concentrated selling occurred in early January 2026, when he disposed of shares worth over $570,000 across multiple transactions, followed by another $837,000 in sales in February. The transactions suggest a steady reduction in his holdings, with no offsetting buys during this period. While the sales could reflect routine portfolio management, the absence of any recent purchases and the scale of disposals—particularly the $510,000 and $460,000 transactions in late December 2025—indicate a directional shift away from accumulating additional exposure to ANAB. The activity remains confined to AnaptysBio, with no trades in other securities disclosed in the filings.
AI-assisted summary